tirzepatide insulin sensitivity for the treatment of adults with type 2 diabetes: An endocrine perspective Frontiers | Tirzepatide against obesity

Working with a registered dietitian or your healthcare provider can help you identify your personal tolerance levels and adjust your fat intake accordingly

Obesity-associated inflammation accelerates NAD consumption through activation of NAD-utilizing enzymes such as poly(ADP-ribose) polymerase 1 (PARP-1) and cluster of differentiation 38 (CD38) [85]

It is not classified as a serious adverse effect and does not typically warrant discontinuation of therapy

2 Work with your prescriber on the PA and state-PDL step documentation Your prescriber must document your confirmed T2D diagnosis and prior use of metformin

Greig, C., Finch, K

This is an off-label combination